KNOLL CAPITAL MANAGEMENT, LP Information

5 EAST 44TH STREET, NEW YORK, New York, 10017, (212) 808-7474

Report Date: 09/30/2014

Position Statistics

Total Positions 17
New Positions 2
Increased Positions 3
Decreased Positions 4
Positions with Activity 7
Sold Out Positions 2
Total Mkt Value (in $ millions) 274

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 97.09%
Services
Technology
Transportation
Utilities

17 Positions as of 09/30/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
MEDIVATION INC COM 238,525 -3,719 (1.54) 2,244,519
AMPIO PHARMACEUTICALS INC COM 15,944 1,922 13.71 3,370,822
ALCOBRA LTD SHS 4,397 New 687,000
NEWLINK GENETICS CORP COM 3,051 New 77,437
BIO BLAST PHARMA LTD SHS 2,745 2,745 New 338,110
KERYX BIOPHARMACEUTICALS INC COM 2,646 New 200,000
SYNTHETIC BIOLOGICS INC COM 2,081 New 1,360,000
ADVAXIS INC COM NEW 1,739 New 225,000
INOVIO PHARMACEUTICALS INC COM NEW 879 New 102,088
ADVAXIS INC WT EXP 071518 511 New 112,500
NORTHWEST BIOTHERAPEUTICS INC COM PAR $0.001 421 -837 (66.53) 67,035
GALMED PHARMACEUTICALS LTD SHS 417 New 65,000
NEPHROGENEX INC COM 413 New 50,000
PROVECTUS BIOPHARMACEUTICALS I COM 161 New 200,000
CELLECTAR BIOSCIENCES INC COM NEW 37 37 New 14,634
CELSUS THERAPEUTICS PLC SPONSORED ADR NE -80 Sold Out 0
ECHO THERAPEUTICS INC COM NEW -57 Sold Out 0


Latest News Headlines

View All
Create your free portfolio